Back to top

Empowering Science, Impacting Humanity

People-
powered
medicine

Funding and tokenization platform for biopharma intellectual property.

$170M+
Ecosystem Market Cap
$7.85M
Total Funded
25K+
Community Members
35
Research Projects Funded
For Funders

Fund Science

Fueling scientific advancements through democratized research funding and tokenized intellectual property.

Top DeSci Projects

Discover the best projects in the ecosystem, whether they are launching soon, fundraising, or already tokenized.

Ecosystem Overview

Decentralised global communities of science or BioDAOs that are part of BIO

Funding Entity
Category
Treasury
Hide this column
Total Projects
Funded
Token
Forum
Longevity
$ 8,825,000
21
-
$ 4,210,000
Women's Health
$ 432,000
2
-
$ 220,000
Hair Loss
$ 3,320,000
1
-
$ 119,000
Synthetic Biology
$ 836,000
1
-
£ 249,000
Psychedelics
$ 2,000,000
3
-
$ 100,000
Cryopreservation
$ 3,760,000
2
-
$ 100,000
Brain Health
$ 900,000
6
-
$ 625,000
News & Content

Molecule News

Stay informed and inspired. Explore Molecule’s news and fresh content.

Apr 24, 2025
read

The DeSci Ecosystem is Growing, and So Are We

When we started building Molecule, we were driven by a simple yet powerful belief: scientific research deserves a new model, one that places discoveries in the commons, empowers researchers, and meaningfully engages global communities.  

We believed blockchain technology could enable a new model for how scientific research is supported and stewarded, making breakthrough discoveries transparent, accessible, and scalable.That belief hasn’t changed, but the ecosystem has grown dramatically. Over the past two years, intellectual property (IP) tokens have evolved from theory to reality. We’ve seen DAO-led biotech funds take shape, early-stage projects tokenize their research, and entire scientific communities begin to organize around programmable IP. But navigating this emerging landscape has been difficult due to fragmented information and limited visibility. That’s about to change. 

Your New Command Centre for Decentralized Science

We’ve rebuilt Molecule from the ground up to serve as a discovery engine for tokenized scientific IP

  • Explore the IP token ecosystem
    Search by research areas or filter by chain. Quickly surface trending projects and market movements.
  • Trade IP tokens directly
    Connect your wallet and seamlessly manage your tokenized IP portfolio all in one place.
  • Track token data, volume, and holders
    Get real-time insights into what’s moving - and who’s backing it.
  • Dive deeper into projects
    Understand the science, funding, and communities behind every token.

It’s a simple interface representing an emerging ecosystem. And it’s built not just for today, but ready to grow along DeSci itself. 

Built for the Community, Shaped by the Community.

Exploring scientific IP tokens should be as intuitive as browsing DeFi protocols or an NFT marketplace. That means making the ecosystem data visible, understandable, and actionable - not fragmented and buried in PDFs or block explorers. It means helping curious researchers become contributors, helping token holders become stewards, and helping scientific communities coordinate around shared incentives.

We’re starting simple: a clear map of the IP token ecosystem, updated in real-time, available to everyone. But we’re building toward much more.

We’re launching this as a public beta—open access, open feedback, open collaboration. Whether you already hold IP tokens or you're simply DeSci-curious, we want your input to shape the future of this platform. Start exploring Molecule.xyz.

About Molecule

Molecule is dedicated to advancing scientific research through democratized funding and the tokenization of intellectual property (IP). By transforming IP into liquid, onchain assets, Molecule aligns the incentives of researchers and funders, fostering a more collaborative and efficient research ecosystem.

Cansu Yanik
Apr 23, 2025
read

A Global Alarm: The Impact of U.S. Science Funding Reductions

Recent reductions in funding across key U.S. health agencies have sent shockwaves through the global scientific community. At the center of this crisis is a $4 billion freeze on National Institutes of Health (NIH) funding - a decision that risks undermining the very foundation of biomedical innovation.

This isn't just a line item on a federal budget. It’s a direct hit to early-stage research, and the impact on long-term drug development and the overall health infrastructure will be lasting and profound.

Once again, the need to build a steadfast scientific funding infrastructure has become evident. At Molecule, we’re not waiting for old systems to catch up. We’re building a system that empowers scientists with the agility, financial independence, and support they need to thrive in this new era of research.

Have you been impacted by funding cuts? We’re helping researchers across the globe source funding for critical research. Contact us today to learn more. 

Billions Lost, Thousands at Risk: The Real Cost of NIH Cuts

With an annual budget of approximately $48 billion, the NIH is responsible for funding up to 94% of all biomedical research in the U.S. This support is foundational. NIH-backed research has played a role in 99% of the drugs approved between 2010 and 2019.

But in recent months, the NIH has faced swift and extreme funding cuts, leaving many researchers completely impeded. Those who have escaped the cuts live in uncertainty, unable to predict the new funding landscape they are faced with. Karlin Compton, a PhD candidate at Northwestern University shared; "As a researcher in biology, our entire field benefits from NIH funding in some way. New government officials believe they’re changing research for the better, but instead they’re disrupting the groundbreaking work people are doing and causing irreparable damage to the synergistic relationship between governmental funding and research for the greater good that took decades to establish. Young graduate students, especially those like me from diverse and disadvantaged backgrounds are feeling nothing but uncertainty and fear at how we are going to be able to not only perform research and publish our work, but also support ourselves and our families."

The reductions include a dramatic cut in indirect cost reimbursement, from an average of 30% (with some institutions receiving up to 70%) to a flat 15%. This shift threatens to eliminate ~$5 billion annually from the budgets of academic and research hospitals, undermining the operational capacity of these institutions.

View the interactive map.

These cancellations are already causing ripple effects, shutting down promising research, and pausing projects that address pressing public health challenges. Across social media and institutional forums, scientists are raising alarm: stalled grants, lost renewals, and disappearing career paths. The research community is facing a climate of fear and instability.

Up to 5,000 NIH staff positions (25% of its workforce) are at risk, alongside thousands of jobs at universities and hospitals nationwide. The cost isn’t just financial. It’s human, and it’s happening now.

The Ripple Effect of Budget Cuts

NIH funding is not simply an expense; it’s an investment that yields considerable returns. Data shows that every $1 invested in NIH funding generates $2.46 in economic activity. By slashing NIH funding, these economic returns are put in jeopardy; a $4 billion reduction could result in a $10 billion loss to the economy, affecting not only the scientific community but also the large industries that depend on biomedical research.

Finding Hope: How DeSci Offers Solutions in the Face of Funding Uncertainty

Scientists are feeling afraid. The world they woke up in has changed, and the reliability of these legacy institutions has been called into question. But, this is not all bad. Times of disruption can catalyze great change and the adoption of new systems.

It has long been clear that the traditional funding model is too slow and fragile for today’s pace of innovation. It's more important than ever to adopt models that prioritize scientific progress. With lay-offs and funding cuts threatening the progress of scientific research in the U.S., decentralized science (DeSci) is a critical balm addressing the challenges faced by the scientific community today.

DeSci is a global movement that leverages technological advancements such as blockchain technology to make science accessible, equitable, and fast. It challenges the bottlenecks of legacy systems by unlocking new paths for funding, collaboration, and ownership in research.

At Molecule, we are building a system that gives scientists the agility and financial independence they need, ensuring they secure the support to continue their work in a community-driven science ecosystem.

A New Era for Science: Empowering Innovation Through DeSci

DeSci has already quietly been reshaping scientific funding.

Take VITA-RNA for example, which is focused on innovative RNA therapies, exemplifies what happens when scientists step outside the broken funding system. Supported by Molecule’s decentralized intellectual property (IP) protocol, Dr Michael Torres and his team were able to secure the resources needed to advance their research. Their science accelerated because they weren't constantly fighting the system designed to support them.

Similarly, Karda Forge raised $200K in 26 minutes - a far cry from the months that typical grant applications take. Today, critical research into biomining and e-waste is occurring because of support from the DeSci ecosystem. 

These success stories signify a shift. There are viable alternative pathways for scientists facing today's unprecedented funding challenges.

Ready to Explore Alternatives?

If you're a researcher affected by these recent challenges, we're here to explore how alternative solutions might support your invaluable work. 

We’d love to talk to you.

Cansu Yanik
Mar 14, 2025
read

Welcome to the latest building block of Molecule’s IP Protocol, Proof of Invention! 

PoI offers a seamless, affordable, and secure way to prove ownership of your innovative ideas. Whether you're an early-stage inventor or part of a decentralized scientific community, PoI provides a timestamped, verifiable proof of creation, empowering you to protect and manage your ideas more efficiently. Here’s how you can get started with PoI.

‍Step 1: Visit Molecule’s Website

Start by heading over to Molecule’s website. Once you're there, look for the 'Create' button on the homepage. Click on it to begin the process of registering your invention and creating your PoI.

This will guide you to the PoI platform where you can securely submit your invention details and generate the unique, timestamped proof linked to your wallet.


Step 2: Login or Connect Your Wallet

To get started with creating your Proof of Invention, you'll need to log in to the platform.

Connect with Web3 Wallet: You can connect with a Web3 wallet like MetaMask. If you don’t already have one, download the MetaMask extension or MetaMask app by following the setup guide.

Log In with email or socials: Alternatively, you can log in using your e-mail address or your Google account.

Step 3: Present Your Invention

Once you’ve logged in, you can securely submit the confidential files that describe your invention. Rest assured, your content remains private, nothing is disclosed during this process.

Step 4: Upload Your Invention Files

Drag and drop your files, or select the files and folders from your device that describe your invention. 

Ideally, add a plain README.md text file to your PoI files. This file is optional, but if you choose to make it publicly visible later, it allows others to understand and reasoning behind your innovation.

After uploading your invention files, click on “Create PoI root” to register you PoI.

Step 4: Confirm via Your Wallet to Generate PoI

Once your invention files are uploaded, you'll need to confirm the transaction in your wallet to generate the Proof of Invention (PoI). This action links the unique, timestamped cryptographic hash to your wallet, securing your intellectual property with verifiable proof of creation.

Simply approve the request in your wallet to complete the process and finalize the generation of your PoI.

Step 5: Verify Ownership and Access Your PoI

Once your PoI is registered, click on "My Inventions" to access the PoI root and view your registered invention. This is where you can track and manage your PoIs, ensuring your IP is securely stored and easily accessible.

You can easily prove you're the original creator at any point in time by revealing only a portion of your invention. This ensures that your intellectual property remains secure and verifiable without disclosing sensitive details.

You're Ready to Protect Your Invention!

That's it! You've successfully registered and timestamped your PoI, and are ready to verify ownership. By using this innovative onchain solution, you're not only securing your intellectual property with verifiable proof of creation but also taking control of how your innovations are protected. 

Welcome to the future of IP!

The upside to founders and researchers are significantly more favorable, especially for early stage research and drug development. The VITARNA project by ArtanBio is living and breathing due to DeSci, VitaDAO and Molecule.

Michel Torres

Principal Investigator, ARTANBio

For me VitaDAO's funding, using Molecule's technology, was a blessing as it initiated early stages of drug screening/discovery, something that traditional VC would be reluctant to do. This enabled us to develop and polish the pipeline of assays which became a major asset for my lab.

Victor Korolchuk

Professor of Cell Biology, Newcastle University

"Molecule is a leader of the “new fashion” on how to distribute private funds to the most competitive and deserving scientists: it delivers funds in a fast, fair, and low working load manner."

Evandro Fang

Lead Researcher

“Molecule has not just paved the way for innovative funding of scientific research, but has also welcomed everyone to participate in molding the next era of medicine.”

Morten Scheibye-Knudsen

Lead Researcher